▶ 調査レポート

鎮痛剤の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Pain Management Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。鎮痛剤の世界市場 2020年:企業別、地域別、種類・用途別 / Global Pain Management Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-16320資料のイメージです。• レポートコード:D0804-16320
• 出版社/出版日:GlobalInfoResearch / 2020年7月28日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、127ページ
• 納品方法:Eメール
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、鎮痛剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。鎮痛剤の種類別市場規模(ジェネリックオピオイド、ブランドオピオイド、NSAID、その他)、用途別市場規模(病院、ドラッグストア、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Endo、Sanofi、Pfizer、Eli Lilly、Grunenthal、Yunnan Baiyao、AstraZeneca、Bayer、Merck、Allergan、Teikoku Seiyaku、Assertio Therapeutics、Teva、J&J
・地域別グローバル市場分析 2015年-2020年
・鎮痛剤の北米市場(アメリカ、カナダ、メキシコ)
・鎮痛剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・鎮痛剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・鎮痛剤の南米市場(ブラジル、アルゼンチン)
・鎮痛剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ジェネリックオピオイド、ブランドオピオイド、NSAID、その他
・用途別分析:病院、ドラッグストア、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Pain Management Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Pain Management Drugs sales will be xx in 2020 from Pain Management Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Pain Management Drugs market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Pain Management Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Pain Management Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Pain Management Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pain Management Drugs market has been segmented into:
Generic Opioids
Branded Opioids
NSAIDs
Others

By Application, Pain Management Drugs has been segmented into:
Hospitals
Drugstores
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pain Management Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pain Management Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pain Management Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Pain Management Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Pain Management Drugs Market Share Analysis
Pain Management Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pain Management Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pain Management Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Pain Management Drugs are:
GSK
Endo
Sanofi
Pfizer
Eli Lilly
Grunenthal
Yunnan Baiyao
AstraZeneca
Bayer
Merck
Allergan
Teikoku Seiyaku
Assertio Therapeutics
Teva
J&J

レポート目次

1 Pain Management Drugs Market Overview
1.1 Product Overview and Scope of Pain Management Drugs
1.2 Classification of Pain Management Drugs by Type
1.2.1 Global Pain Management Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pain Management Drugs Revenue Market Share by Type in 2019
1.2.3 Generic Opioids
1.2.4 Branded Opioids
1.2.5 NSAIDs
1.2.6 Others
1.3 Global Pain Management Drugs Market by Application
1.3.1 Overview: Global Pain Management Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Pain Management Drugs Market by Regions
1.4.1 Global Pain Management Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pain Management Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pain Management Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pain Management Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pain Management Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pain Management Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pain Management Drugs Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Pain Management Drugs Industry Impact
1.5.1 COVID-19 Potential Implications for the Pain Management Drugs
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Pain Management Drugs
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Endo
2.2.1 Endo Details
2.2.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Endo SWOT Analysis
2.2.4 Endo Product and Services
2.2.5 Endo Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Grunenthal
2.6.1 Grunenthal Details
2.6.2 Grunenthal Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Grunenthal SWOT Analysis
2.6.4 Grunenthal Product and Services
2.6.5 Grunenthal Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yunnan Baiyao
2.7.1 Yunnan Baiyao Details
2.7.2 Yunnan Baiyao Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Yunnan Baiyao SWOT Analysis
2.7.4 Yunnan Baiyao Product and Services
2.7.5 Yunnan Baiyao Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Allergan SWOT Analysis
2.11.4 Allergan Product and Services
2.11.5 Allergan Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teikoku Seiyaku
2.12.1 Teikoku Seiyaku Details
2.12.2 Teikoku Seiyaku Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teikoku Seiyaku SWOT Analysis
2.12.4 Teikoku Seiyaku Product and Services
2.12.5 Teikoku Seiyaku Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Assertio Therapeutics
2.13.1 Assertio Therapeutics Details
2.13.2 Assertio Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Assertio Therapeutics SWOT Analysis
2.13.4 Assertio Therapeutics Product and Services
2.13.5 Assertio Therapeutics Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Teva SWOT Analysis
2.14.4 Teva Product and Services
2.14.5 Teva Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 J&J
2.15.1 J&J Details
2.15.2 J&J Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 J&J SWOT Analysis
2.15.4 J&J Product and Services
2.15.5 J&J Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pain Management Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pain Management Drugs Players Market Share
3.2.2 Top 10 Pain Management Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pain Management Drugs Revenue and Market Share by Regions
4.2 North America Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pain Management Drugs Revenue and Growth Rate (2015-2020)
5 North America Pain Management Drugs Revenue by Countries
5.1 North America Pain Management Drugs Revenue by Countries (2015-2020)
5.2 USA Pain Management Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Pain Management Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Pain Management Drugs Revenue and Growth Rate (2015-2020)
6 Europe Pain Management Drugs Revenue by Countries
6.1 Europe Pain Management Drugs Revenue by Countries (2015-2020)
6.2 Germany Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.4 France Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Pain Management Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pain Management Drugs Revenue by Countries
7.1 Asia-Pacific Pain Management Drugs Revenue by Countries (2015-2020)
7.2 China Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.5 India Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pain Management Drugs Revenue and Growth Rate (2015-2020)
8 South America Pain Management Drugs Revenue by Countries
8.1 South America Pain Management Drugs Revenue by Countries (2015-2020)
8.2 Brazil Pain Management Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Pain Management Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pain Management Drugs by Countries
9.1 Middle East & Africa Pain Management Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Pain Management Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pain Management Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Pain Management Drugs Market Forecast by Type (2019-2024)
10.3 Generic Opioids Revenue Growth Rate (2015-2025)
10.4 Branded Opioids Revenue Growth Rate (2015-2025)
10.5 NSAIDs Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Pain Management Drugs Market Segment by Application
11.1 Global Pain Management Drugs Revenue Market Share by Application (2015-2020)
11.2 Pain Management Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Drugstores Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Pain Management Drugs Market Size Forecast (2021-2025)
12.1 Global Pain Management Drugs Market Size Forecast (2021-2025)
12.2 Global Pain Management Drugs Market Forecast by Regions (2021-2025)
12.3 North America Pain Management Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Pain Management Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pain Management Drugs Revenue Market Forecast (2021-2025)
12.6 South America Pain Management Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pain Management Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Pain Management Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pain Management Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pain Management Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pain Management Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Pain Management Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GSK Corporate Information, Location and Competitors
Table 7. GSK Pain Management Drugs Major Business
Table 8. GSK Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 9. GSK SWOT Analysis
Table 10. GSK Pain Management Drugs Product and Solutions
Table 11. GSK Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Endo Corporate Information, Location and Competitors
Table 13. Endo Pain Management Drugs Major Business
Table 14. Endo Pain Management Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Endo SWOT Analysis
Table 16. Endo Pain Management Drugs Product and Solutions
Table 17. Endo Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sanofi Corporate Information, Location and Competitors
Table 19. Sanofi Pain Management Drugs Major Business
Table 20. Sanofi Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Sanofi SWOT Analysis
Table 22. Sanofi Pain Management Drugs Product and Solutions
Table 23. Sanofi Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer Pain Management Drugs Major Business
Table 26. Pfizer Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer Pain Management Drugs Product and Solutions
Table 29. Pfizer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Eli Lilly Corporate Information, Location and Competitors
Table 31. Eli Lilly Pain Management Drugs Major Business
Table 32. Eli Lilly Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Eli Lilly SWOT Analysis
Table 34. Eli Lilly Pain Management Drugs Product and Solutions
Table 35. Eli Lilly Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Grunenthal Corporate Information, Location and Competitors
Table 37. Grunenthal Pain Management Drugs Major Business
Table 38. Grunenthal Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Grunenthal SWOT Analysis
Table 40. Grunenthal Pain Management Drugs Product and Solutions
Table 41. Grunenthal Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Yunnan Baiyao Corporate Information, Location and Competitors
Table 43. Yunnan Baiyao Pain Management Drugs Major Business
Table 44. Yunnan Baiyao Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Yunnan Baiyao SWOT Analysis
Table 46. Yunnan Baiyao Pain Management Drugs Product and Solutions
Table 47. Yunnan Baiyao Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. AstraZeneca Corporate Information, Location and Competitors
Table 49. AstraZeneca Pain Management Drugs Major Business
Table 50. AstraZeneca Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 51. AstraZeneca SWOT Analysis
Table 52. AstraZeneca Pain Management Drugs Product and Solutions
Table 53. AstraZeneca Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bayer Corporate Information, Location and Competitors
Table 55. Bayer Pain Management Drugs Major Business
Table 56. Bayer Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Bayer SWOT Analysis
Table 58. Bayer Pain Management Drugs Product and Solutions
Table 59. Bayer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Merck Corporate Information, Location and Competitors
Table 61. Merck Pain Management Drugs Major Business
Table 62. Merck Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 63. Merck SWOT Analysis
Table 64. Merck Pain Management Drugs Product and Solutions
Table 65. Merck Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Allergan Corporate Information, Location and Competitors
Table 67. Allergan Pain Management Drugs Major Business
Table 68. Allergan Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Allergan SWOT Analysis
Table 70. Allergan Pain Management Drugs Product and Solutions
Table 71. Allergan Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Teikoku Seiyaku Corporate Information, Location and Competitors
Table 73. Teikoku Seiyaku Pain Management Drugs Major Business
Table 74. Teikoku Seiyaku Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Teikoku Seiyaku SWOT Analysis
Table 76. Teikoku Seiyaku Pain Management Drugs Product and Solutions
Table 77. Teikoku Seiyaku Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Assertio Therapeutics Corporate Information, Location and Competitors
Table 79. Assertio Therapeutics Pain Management Drugs Major Business
Table 80. Assertio Therapeutics Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 81. Assertio Therapeutics SWOT Analysis
Table 82. Assertio Therapeutics Pain Management Drugs Product and Solutions
Table 83. Assertio Therapeutics Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Teva Corporate Information, Location and Competitors
Table 85. Teva Pain Management Drugs Major Business
Table 86. Teva Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 87. Teva SWOT Analysis
Table 88. Teva Pain Management Drugs Product and Solutions
Table 89. Teva Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. J&J Corporate Information, Location and Competitors
Table 91. J&J Pain Management Drugs Major Business
Table 92. J&J Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 93. J&J SWOT Analysis
Table 94. J&J Pain Management Drugs Product and Solutions
Table 95. J&J Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Pain Management Drugs Revenue (Million USD) by Players (2015-2020)
Table 97. Global Pain Management Drugs Revenue Share by Players (2015-2020)
Table 98. Global Pain Management Drugs Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Pain Management Drugs Revenue Market Share by Regions (2015-2020)
Table 100. North America Pain Management Drugs Revenue by Countries (2015-2020)
Table 101. North America Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Europe Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Pain Management Drugs Revenue by Countries (2015-2020)
Table 105. South America Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Pain Management Drugs Revenue (Million USD) by Type (2015-2020)
Table 109. Global Pain Management Drugs Revenue Share by Type (2015-2020)
Table 110. Global Pain Management Drugs Revenue Forecast by Type (2021-2025)
Table 111. Global Pain Management Drugs Revenue by Application (2015-2020)
Table 112. Global Pain Management Drugs Revenue Share by Application (2015-2020)
Table 113. Global Pain Management Drugs Revenue Forecast by Application (2021-2025)
Table 114. Global Pain Management Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pain Management Drugs Picture
Figure 2. Global Pain Management Drugs Revenue Market Share by Type in 2019
Figure 3. Generic Opioids Picture
Figure 4. Branded Opioids Picture
Figure 5. NSAIDs Picture
Figure 6. Others Picture
Figure 7. Pain Management Drugs Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Drugstores Picture
Figure 10. Others Picture
Figure 11. Global Pain Management Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Pain Management Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Pain Management Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Pain Management Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Pain Management Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Pain Management Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Pain Management Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 44. China Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Pain Management Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Pain Management Drugs Revenue Share by Type in 2019
Figure 61. Global Pain Management Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Generic Opioids Revenue Growth Rate (2015-2020)
Figure 63. Global Branded Opioids Revenue Growth Rate (2015-2020)
Figure 64. Global NSAIDs Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Pain Management Drugs Revenue Share by Application (2015-2020)
Figure 67. Global Pain Management Drugs Revenue Share by Application in 2019
Figure 68. Global Pain Management Drugs Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Drugstores Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Pain Management Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Pain Management Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Pain Management Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel